麻豆传媒

The OCTDI builds on the strengths of the UB Department of Biostatistics, with faculty affiliated with all UB health science schools and the UB Institute for Artificial Intelligence and Data Science.

The services provided by the OCTDI complement those of the UB Clinical and Translational Science Institute (CTSI) Biostatistics, Epidemiology, and Research Design (BERD) Core, which spans the Departments of Biostatistics and Epidemiology & Environmental Health in the School of Public Health and Health Professions, as well as the Department of Biostatistics & Bioinformatics at Roswell Park Comprehensive Cancer Center. 

The OCTDI is positioned to interact with and complement other units involved in research advancement facilitation, intervention development, and research implementation.

The OCTDI, with support from the Office of the Vice President for Health Sciences and alliance with the Office of the Dean for the School of Public Health and Health Professions, BERD faculty, and the UB Department of Biostatistics, is committed to supporting quality clinical research and statistical literacy at UB.

• Evaluation of drugs, medical devices, preventions, procedures, behavioral interventions, education interventions, diagnostic tools and delivery systems 
• Early-phase (pilot/feasibility, phase I and II, dose-finding, proof-of-concept) and late-phase (confirmatory, phase III-IV) trials 
• Analyses to establish superiority, noninferiority or equivalence 
• Single and multi-site trials
• Parallel group, cross-over, factorial, stepped-wedge, cluster randomized, individual-randomized group treatment study designs 
• Adaptive design (trials which allow for early stopping, sample size re-estimation, adding or dropping arms, etc.) 
• Explanatory (under ideal conditions) and pragmatic (real-world setting) trials